Search for: "Takeda Pharmaceuticals International" Results 1 - 20 of 69
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, and Takeda Pharmaceuticals America, Inc.) sued to enjoin Defendants from marketing generic versions on the basis of inducing and/or contributorily infringing various patents, including U.S. [read post]
26 Apr 2021, 7:42 am by Race to the Bottom
Moderna also entered into deals with Catalent Inc. and Baxter International Inc. to help fill vaccine vials, and Takeda will use an existing facility in Japan to manufacture, import, and distribute vaccines. [read post]
2 Apr 2020, 6:30 am by Andrew Hamm
Takeda Pharmaceutical Co. v. [read post]
4 Mar 2020, 7:11 am by Wim Vandenberghe
The Innovative Medicines Initiative (IMI) was created in 2008 as a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).[1] Its overall goal is to increase the competitiveness of R&D in the European pharmaceutical sector by encouraging companies to work with each other and with the public sector. [read post]
30 Apr 2019, 7:22 am
  Prior to 2017, Canada had been the only G7 nation not to provide patent term extension for pharmaceutical products and was pressured into adopting this by the EU. [read post]
6 Aug 2018, 11:50 am by James Innocent
Takeda’s internal safety research didn’t reflect these problems, leading some to question their methods. [read post]
14 Dec 2017, 10:48 pm by GJEL
Actos diabetes drugs $2.4 billion In 2015, a federal judge in Louisiana reported that a Japanese drug company, Takeda Pharmaceutical, had agreed to pay $2.4 billion over claims that Takeda concealed the safety risks of its Actos diabetes drug before regulators warned that extended use could cause bladder cancer. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
3 May 2016, 9:00 pm by Dennis Crouch
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1]  On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
29 Apr 2016, 10:04 am by Law Offices of Jeffrey S. Glassman
Takeda Pharmaceuticals, the makers of Actos, on the other hand, disagree with the link between their popular diabetes medication and bladder cancer and cite their own study data, which does not show such a causal link. [read post]
21 May 2015, 8:25 am by Rosenfeld Injury Lawyers
However, in information released at trial, internal studies by the pharmaceutical manufacturer as far back as 2004 linked the drug to an increased risk in bladder cancer. [read post]
21 May 2015, 8:25 am by Rosenfeld Injury Lawyers
However, in information released at trial, internal studies by the pharmaceutical manufacturer as far back as 2004 linked the drug to an increased risk in bladder cancer. [read post]
21 May 2015, 8:25 am by Rosenfeld Injury Lawyers
However, in information released at trial, internal studies by the pharmaceutical manufacturer as far back as 2004 linked the drug to an increased risk in bladder cancer. [read post]
21 May 2015, 8:25 am by Rosenfeld Injury Lawyers
However, in information released at trial, internal studies by the pharmaceutical manufacturer as far back as 2004 linked the drug to an increased risk in bladder cancer. [read post]
2 Apr 2015, 7:32 am by Joe Consumer
  Takeda Pharmaceuticals, Asia’s largest drugmaker, has offered to pay more than $2.2 billion to settle claims that it hid the cancer risks associated with its Actos diabetes medicine. [read post]